SABRATEK CORP
SC 13D/A, 1997-05-28
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: SUSA PARTNERSHIP LP, 8-K, 1997-05-28
Next: UGLY DUCKLING CORP, 424B3, 1997-05-28





- --------------------------------------------------------------------------------

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13D


                    Under the Securities Exchange Act of 1934
                               (Amendment No. 1 )*


                              Sabratek Corporation
                                (Name of Issuer)

                                  Common Stock
                         (Title of Class of Securities)

                                  78571 U 10 8
                                 (Cusip Number)

                               Charles K. Stewart
  401 South LaSalle Street, Suite 1502, Chicago, Illinois 60605 (312) 786-9907
           (Name, Address and Telephone Number of Person Authorized to
                       Receive Notes and Communications)


                                  April 9, 1997
             (Date of Event which Requires Filing of this Statement)

   If the filing  person has  previously  filed a statement  on Schedule  13G to
   report the  acquisition  which is the subject of this  Schedule  13D,  and is
   filing this schedule  because of Rule 13d-1(b)(3) or (4), check the following
   box |_|.

   Check the following box if a fee is being paid with the statement |_|. (A fee
   is not required only if the reporting person: (1) has a previous statement on
   file reporting beneficial ownership of more than five percent of the class of
   securities  described  in Item 1; and (2) has filed no  amendment  subsequent
   thereto  reporting  beneficial  ownership  of  five  percent  or less of such
   class.) (See Rule 13d-7.)

   Note: Six copies of this statement,  including all  exhibits, should be filed
   with the Commission. See Rule 13a-1(a) for other  parties to whom  copies are
   to be sent.

   *The  remainder  of this  cover  page  shall be  filled  out for a  reporting
   person's  initial  filing on this form with  respect to the subject  class of
   securities,  and for any subsequent  amendment  containing  information which
   would alter disclosures provided in a prior cover page

   The  Information  required on the  remainder  of this cover page shall not be
   deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
   Act of 1934 ("Act") or otherwise  subject to the  liabilities of that section
   of the Act but shall be subject to all other  provisions of the Act (however,
   see the Notes).











- --------------------------------------------------------------------------------



<PAGE>









                                  SCHEDULE 13D
- ----------------------------          ------------------------------------------
CUSIP No. 78571 U 10 8                  Page       2       of       4      Pages

- ----------------------------          ------------------------------------------


- --------------------------------------------------------------------------------
  1      NAME OR REPORTING PERSON
         S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON


            Charles K. Stewart S.S.N.:  ###-##-####
- --------------------------------------------------------------------------------
  2      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                       (a) |X|
                                                                       (b) |_|
- --------------------------------------------------------------------------------
  3      SEC USE ONLY


- --------------------------------------------------------------------------------
  4      SOURCE OF FUNDS*

            PF
- --------------------------------------------------------------------------------
  5      CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO 
         ITEMS 2(d) or 2(e)                                             |_|


- --------------------------------------------------------------------------------
  6      CITIZENSHIP OR PLACE OF ORGANIZATION

            The United States of America
- --------------------------------------------------------------------------------

                            7       Sole Voting Power          507,688
      NUMBER OF
       SHARES         ----------------------------------------------------------
    BENEFICIALLY            8       Shared Voting Power           0             
      OWNED BY        ----------------------------------------------------------
        EACH                9       Sole Dispositive Power     507,688          
      REPORTING       ----------------------------------------------------------
       PERSON              10       Shared Dispositive Power      0             
        WITH          
                    
 -------------------------------------------------------------------------------
   11       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

                     507,688
- --------------------------------------------------------------------------------
   12       CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN 
            SHARES*                                                      |_|


- --------------------------------------------------------------------------------
   13       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

                     4.71%
- --------------------------------------------------------------------------------
   14       TYPE OF PERSON REPORTING*

                     IN   EP
- --------------------------------------------------------------------------------
                      *SEE INSTRUCTIONS BEFORE FILLING OUT!
          INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
       (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION




<PAGE>



                                                --------------------------------
                                                        Page  3  of  4  Pages
                                                --------------------------------



Item 1.           Security and Issuer.

     This  Amendment to Schedule 13-D,  dated May 28, 1997,  filed by Charles K.
Stewart, relates to the common stock, par value of $.01 per share (the "Sabratek
Common Stock"), of Sabratek Corporation, a Delaware corporation (the "Issuer" or
"Sabratek").  The principal  executive offices of the Issuer are located at 5601
West Howard Street,  Niles,  Illinois 60714.  All capitalized  terms used herein
shall have the definitions set forth in the Schedule, except as may otherwise be
provided herein.

Item 2.           Identity and Background.

     This statement is being filed by Charles K. Stewart.  His business  address
is 401 South LaSalle Street, Suite 1502, Chicago, Illinois 60605.

     During the last five  years,  Mr.  Stewart  has never been  convicted  in a
criminal proceeding (excluding traffic violations or similar misdemeanors),  nor
has he been party to a civil proceeding of a judicial or administrative  body of
competent  jurisdiction  as a result of which Mr. Stewart was or is subject to a
judgment,  decree or final order enjoining future  violations of, or prohibiting
or mandating  activities subject to, federal or state securities laws or finding
any violation with respect to such laws.

Item 3.           Source and Amount of Funds or Other Consideration.


     The source and  amount of funds used by Mr.  Stewart to acquire  securities
were  disclosed  in his previous  Schedule  13D. On April 9, 1997,  Mr.  Stewart
purchased  15,000 shares of Sabratek Common Stock at $18.00 per share in an open
market transaction. He sold 10,000 shares at $23.00 per share on April 14, 1997,
2,000  shares at $22 1/2 per share and 3,000  shares at $23.00 per share in open
market transactions.




<PAGE>


                                                     ---------------------------
                                                         Page  4  of  4  Pages
                                                     ---------------------------


Item 4.           Purpose of Transaction.

                                                              N/A

Item 5.           Interest in Securities of the Issuer.

   As of May 28, 1997, Mr. Stewart is deemed to beneficially  own 507,688 shares
of Sabratek  Common  Stock  (approximately  4.71% of the  Sabratek  Common Stock
outstanding),  which includes 3,939 shares subject to options exercisable by Mr.
Stewart within 60 days. The percentage of Sabratek  Common Stock  outstanding is
calculated based upon information contained in Post-Effective Amendment No. 1 to
the  Issuer's  Registration  Statement  on Form  S-1 as  filed  pursuant  to the
Securities  Act of 1933,  as amended,  which  became  effective on April 4, 1997
(File No.  333-23437).  On April 9, 1997 Mr. Stewart ceased to be the beneficial
owner of more than five (5) percent of the class of securities of the Issuer.

Item 6.           Contracts, Arrangements, Understandings or Relationship with
Respect to Securities of the Issuer.

         NONE

Item 7.           Material to be Filed as Exhibits.

         NONE



                                    SIGNATURE

     After  reasonable  inquiry and to the best of my  knowledge  and belief,  I
certify that the information  set forth in this statement is true,  complete and
correct.

Dated:            May 28, 1997

                                            By:      /S/ Charles K. Stewart
                                                     Name:  Charles K. Stewart










© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission